Document › Details

BioLineRx Ltd.. (8/6/19). "Press Release: BioLineRx Reports Second Quarter 2019 Financial Results and Provides Corporate Update". Tel Aviv.

Organisations Organisation BioLineRx Ltd. (Nasdaq: BLRX, TASE: BLRX)
  Group BioLineRx (Group)
  Organisation 2 LifeSci Advisors LLC
  Group LifeSci (Group)
Products Product BL-8040 (BioLineRx)
  Product 2 AGI-134 (Agalimmune)
Person Person Serlin, Philip A. (BioLineRx 201610– CEO joined 2009 as CFO + COO before Kayote Networks + Tescom Software)
     


   
Record changed: 2019-08-07

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x112px

More documents for BioLineRx (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px




» top